At Ce.B.Tec. we specialize in providing comprehensive consulting services related to production organization, with a focus on leveraging our expertise in biotechnology.
Our experienced team offers valuable insights and guidance to optimize production processes, enhance efficiency, and improve overall performance. By leveraging our knowledge of biotechnology, we assist clients in implementing strategies and practices that lead to increased productivity and success in their respective industries.
We also offer contracted research and development services, with a specific focus on biotechnology. Our team of experts is skilled in developing innovative diagnostic solutions and technologies to address various challenges in the field. Specifically, we develop tailor-made diagnostic solutions and products for a wide variety of targets, including respiratory viruses and chronic disease biomarkers. Through our research and development services, we help our clients stay at the forefront of biotechnology advancements and provide them with cutting-edge solutions.
In addition to our consulting and research and development services, we aspire to provide analytical services to ensure the quality and reliability of of various biotechnological products. Our state-of-the-art facilities and experienced scientists enable us to conduct extract composition/purity control tests and cytotoxicity assays for extracts. We also aim to offer transcriptomic analysis services, which involve studying gene expression patterns and molecular interactions within biological systems. Through our analytical services, we will assist our clients in ensuring the safety, effectiveness, and beneficial properties of their products, actively contributing to the advancement of biotechnology.
We have developed a bioelectric biosensor capable of detecting simultaneously a wide range of respiratory viruses, and their respective antibodies allowing it to serve as a multiplex ultra-rapid diagnostic kit at the PoC. This breakthrough technology enables healthcare professionals to obtain accurate and comprehensive diagnostic information rapidly, leading to improved patient outcomes. The target pathogens can be altered based on market demands within a short time, thanks to the diagnostic platform’s remarkable flexibility.
